Registration for Virtual Fall 2020 Conference: Closed
Endocrine Days Educational Institute Fall 2020 Virtual Agenda
Part I: Virtual Sessions Posted to Endo Days Website to View at Your Leisure
Time: Links go live online Friday, Oct. 16th, 2020 - closes Monday, Nov. 16th, 2020
Part II: Live, Virtual Q&A and Case Discussion
Time: Friday, Nov. 6th, 2020 at 2-4pm (PST)
This activity has been planned and implemented in accordance with accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Washington State Medical Association and Endocrine Days Educational Institute. The WSMA is accredited by the ACCME to provide continuing medical education for physicians.
The WSMA designates this Other (blended internet live and enduring) activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for up to 7.5 hour(s) of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
NOTE: WSMA offers ABIM MOC points for this activity for learners choosing to participate in the MOC program. Learners are NOT required to participate in any MOC activities in order to claim AMA PRA Category 1 Credits™ for this activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Planners: Alan Failor, Bradely Anawalt, Anthoby DeSantis, Jonathan Halldorson, George Moore, Komal Patil-Sisodia, Stephanie Page, Shaista Quddusi, Savitha Subramanian, Michael Tamber, Kristina Utzschneider, Avantika Waring, and Brent Wisse.
The following planners have indicated (a) relevant financial relationship(s) with an ACCME-defined commercial interest:
George Moore, Amgen, speaker training
Kristina Utzschneider, Medtronics, training
Their planning contributions were evidence-based and unbiased.
Faculty: William Young, M.D., Mayumi Endo, M.D., Delphine Chen, M.D., Micheal McClung, M.D., Radhika Narla, M.D., Bradley Anawalt, M.D., and Anthoby DeSantis, M.D.
The following faculty have indicated (a) relevant financial relationship(s) with an ACCME-defined commercial interest:
Michael McClung: Amgen, Myovant Sciences, Consulting
William Young: Bayer, Consulting
Their contributions/presentations will be evidence-based and unbiased.
All others in control of content have indicated no relevant financial relationship with an ACCME-defined commercial interest. All clinical content presented is evidence-based and unbiased.
Part 1: Recordings
Part 1: Recordings
Bone & Osteoporosis
Primary Aldosteronism: The Silent Epidemic
William Young, M.D.
An Update on Bone Forming Agents:
The Emerging Roles of Anabolic Therapies for Osteoporosis
Micheal McClung, M.D.
Radioactive Iodine Therapy and Active Surveillance in Differentiated Thyroid Cancer
Thyroid is out, now what?
Mayumi Endo, M.D.
Update: Pheochromocytoma and Paraganglioma
William Young, M.D.
Osteoporosis in Men: Sex Steroids, Gender Influences on Bone and Aging
Radhika Narla, M.D.
Long Term Osteoporosis Therapy:
What to Do After 5 Years?
Michael McClung, M.D.
PRRT in the Treatment of NETs
Delphine Chen, M.D.
30 minutes on Endocrine Tumors
30 minutes on Bones & Osteoporosis
Bradley Anawalt, M.D.
Anthony DeSantis, M.D.